Borrelia miyamotoi strain CT13-2396

Borrelia miyamotoi strain CT13-2396 is a Gram-negative bacterium notable for its pathogenic potential in humans and other hosts. This strain possesses flagella, which contribute to its motility and ability to infect various organisms, including Homo sapiens, Ixodida, Aves, and Rodentia. Specifically, it has been identified in hard tick species such as Ixodes scapularis, Ixodes persulcatus, Dermacentor reticulatus, Ixodidae, Haemaphysalis concinna, and Ixodes ricinus. The health effects associated with Borrelia miyamotoi strain CT13-2396 are significant, as it is linked to relapsing fever and meningoencephalitis. This bacterium is responsible for Borrelia miyamotoi disease (BMD), which is an emerging disease primarily observed in the Northern Hemisphere. Infections can lead to relapsing fever illness and central nervous system (CNS) infections, underscoring its potential impact on human health. The strain is characterized by a presence of 12 replicons, which may play a role in its genetic diversity and adaptability. This trait, combined with its ability to thrive in various hosts, suggests that Borrelia miyamotoi strain CT13-2396 has significant ecological implications, particularly in the context of tick-borne diseases. Understanding its transmission dynamics and host interactions is crucial for public health strategies aimed at managing and preventing the spread of this emerging pathogen.